Search Posts
Recent Posts
- Gimme’ Shelter: Elvira, here… at the Providence Animal Control Center December 22, 2024
- Ask Chef Walter: Pinoli Biscotti – Chef Walter Potenza December 22, 2024
- Rhode Island Weather for Dec. 22, 2024, Jack Donnnelly December 22, 2024
- Sports in RI: High School winter sports season heats up fast and furious – John Cardullo December 22, 2024
- 50% of us are still paying off Christmas 2023: How to win the balance transfer game – Mary Hunt December 22, 2024
Categories
Subscribe!
Thanks for subscribing! Please check your email for further instructions.
Vaccine Decision – Getting to ‘YES’ – by Herb Weiss
Study Takes Look at Decision Making in Getting a COVID-19 Vaccine
By Herb Weiss, contributing writer on aging
Last month, the first shipment of COVID-19 vaccines came to Rhode Island. With limited stockpiles, debate in the state is heating up as to who gets priority in getting vaccinated. While many Rhode Islanders are waiting for the opportunity to be vaccinated, it has been reported that others, including health care workers, are declining to be inoculated. They turned down the chance to get the COVID-19 vaccine because of their concerns it may not be safe or effective.
Now research studies are being reported as how to increase a person’s likelihood to be vaccinated. Last week, the COVID-19 Vaccine Education and Equity Project Survey, a group whose mission is to increase public dialogue on vaccine education, released survey findings that ranked preferred locations to receive COVID-19 vaccines, as well as leading information sources that would influence a person’s decision to get vaccinated.
The CARAVAN survey was conducted live on December 18-20, 2020 by Engine Insights, among a sample of 1,002 adults over the age of 18 who had previously volunteered to participate in online surveys and polls. The data was weighted to reflect the demographic composition of the population.
The researchers found that nearly two-thirds of the public (63 percent) say they will “definitely” or “probably” get vaccinated against COVID-19. The numbers of those indicating they would “definitely” or “probably” get vaccinated varied widely by race. While 67 percent of white respondents indicated they would get a vaccine, the numbers fell to 58 percent among Hispanic respondents and only 42 percent among Black respondents.
Note, other recent surveys in Texas shows 26% of Hispanic respondents were willing to get the vaccine, as compared with 46% of white respondents in the same area – mostly out of concern of immigration status. Similar figures were seen in Florida and other border states.
Influencing a Person’s Decision to Get a COVID-19 Vaccine
The study, commissioned by the Washington, DC based Alliance for Aging Research, one of the three nonprofit organizations leading the project, found the majority (51 percent) of respondents ranked their healthcare provider or pharmacist as one of the sources most likely to influence their decision to get a COVID-19 vaccine. Almost two-thirds (64 percent) of respondents said they would prefer to receive a COVID-19 vaccine in their healthcare provider’s office.
After healthcare providers and pharmacists, when asked to provide the top two additional sources of information about COVID-19 vaccines that would most influence their decision to get vaccinated, 32 percent of respondents cited nationally recognized health experts, and 30 percent named family and friends. However, older respondents were increasingly more likely (75 percent ages 65 and older) to trust their healthcare provider or pharmacist, followed by 43 percent (ages 65 and older) trusting nationally recognized health experts.
“While we’re encouraged to see the majority of respondents planning to get vaccinated, we need to continue to educate about the safety of receiving COVID-19 vaccines from various healthcare professionals, including pharmacists in drug stores, supermarkets, and vaccine clinics,” said Susan Peschin, President and CEO of the Alliance for Aging Research, in a Jan. 14 statement released announcing the study’s findings. “It is critical to our pursuit of health equity that all Americans have confidence in and access to COVID-19 vaccines,” she said.
Overall, the researchers say that survey responses provided important information about the factors influencing the likelihood to get vaccinated and where respondents prefer to receive COVID-19 vaccinations.
As to the likelihood to be vaccinated, the study’s findings reveal that about a quarter (24 percent) of respondents said they would “probably not” or “definitely not” get a vaccine, with Black respondents more likely to say they would not receive the vaccine (25 percent), compared to Hispanic (15 percent) and white (13 percent) respondents. Respondents that said they will “probably not” get a vaccine also tend to be younger (13 percent ages 18-34, 14 percent ages 35-44).
Identifying Preferred Locations to be Vaccinated
Researchers looked into what is the preferred location to be vaccinated. The survey asked respondents to select one or multiple locations where they would prefer to receive a COVID-19 vaccine. The majority (64 percent) of respondents indicated they would prefer COVID-19 vaccination in their healthcare provider’s office, while 29 percent prefer a pharmacy, 20 percent a drive-thru vaccine clinic, and only 13 percent would like to receive the vaccine at a grocery store pharmacy.
Researchers found a generational split among these options (health care providers office, pharmacy, drive-thru clinic and grocery store-based pharmacy). When asked about their top two considerations, older respondents were much more likely (72 percent ages 65 and older) to cite preference for receiving COVID-19 vaccines in their healthcare provider’s office, compared to over half (56 percent) of respondents ages 18-34. More than a third (36 percent) of those ages 18-34 prefer to be vaccinated at a pharmacy. In evaluating location preferences, nearly two-thirds (61 percent) of respondents said they would prefer to get vaccinated from a healthcare provider they know. This percentage was higher when looking at respondents over the age of 65 (74 percent).
Additional factors driving the location where respondents would like to receive the vaccine included the ability to get the vaccine quickly or not have to wait in line (45 percent) and a location close to home (41 percent), the study found.
Debunking Some Myths and Misconceptions
RIDOH has compiled a listing of frequently asked questions about COVID-19. Here is a sampling:
Some believe that vaccines are ineffective due to the vaccine’s fast track development, fearing corners have been cut during the clinical trials. The Rhode Island Department of Health (RIDOH) stresses that “the vaccines are 95% effective in preventing symptomatic laboratory-confirmed COVID-19 and in preventing severe disease.”
It’s been reported that some people may choose to not get vaccinated because that believe that the vaccine contain a microchip. That’s not true, says RIDOH. “There is no vaccine microchip, and the vaccine will not track people or gather personal information into a database. This myth started after comments made by Bill Gates from the Bill & Melinda Gates Foundation about a digital certificate of vaccine records. The technology he was referencing is not a microchip, has not been implemented in any manner, and is not tied to the development, testing, or distribution of COVID-19 vaccines,” says RIDOH.
Others express concerns that MRNA vaccines can alter your DNA. “The COVID-19 vaccines currently available, which are messenger RNA (mRNA) vaccines, will not alter your DNA. Messenger RNA vaccines work by instructing cells in the body how to make a protein that triggers an immune response, according to CDC. Messenger RNA injected into your body does not enter the cell nucleus where DNA is located and will not interact with or do anything to the DNA of your cells. Human cells break down and get rid of the messenger RNA soon after they have finished using the instructions,” states RIDOH.
A vaccine will not give you COVID-19. RIDOH says: “None of the COVID-19 vaccines currently in development or in use in the US contain the live virus that causes COVID-19. The goal for each of the vaccines is to teach our immune system how to recognize and fight the virus that causes COVID-19. Sometimes this process can cause symptoms, such as fever. These symptoms are normal and are a sign that the body is building immunity. It typically takes a few weeks for the body to build immunity after vaccination. That means it’s possible a person could be infected with the virus that causes COVID-19 just before or just after vaccination and get sick, but this is not because they got the vaccine. This is because the vaccine has not had enough time to provide protection.”
For more resources on the impact of COVID-19 vaccination uptake in protecting individuals, families and communities, and for details on how organizations can partner with the COVID-19 Vaccine Education and Equity Project, visit https://covidvaccineproject.org.
Editor’s note: We could take a page from the book of social media gurus who are always looking for key influencers that they can use to target a specific audience with a specific, tailored message. The CDC has some print ads with graphics of drawn figures, such as this one:
We have local banners featuring RI health leaders that are popping up on Facebook and other websites. Some states with particular challenges have gone all out with creative campaigns such as the Mardi Gras theme from New Orleans, called “Sleeves Up, NOLA!”
We need to do more hyper-local research on who is complying and who is not, and how best to reach them with the messages they need to hear to ease their decision-making.
In Rhode Island:
One from Europe:
Want to know more about COVID-19 Vaccinations? Go to https://health.ri.gov/publications/frequentlyaskedquestions/COVID19-Vaccine.pdf
_____
Herb Weiss, LRI’12, is a Pawtucket writer covering aging, health care and medical issues. To purchase Taking Charge: Collected Stories on Aging Boldly, a collection of 79 of his weekly commentaries, go to herbweiss.com.
Thank you for all of your wonderful work